J. Riesenfeld

发表

N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans.

M. Höök, U. Lindahl, J. Riesenfeld, 1982, Analytical biochemistry.

Extension and structural variability of the antithrombin-binding sequence in heparin.

K. Nordling, I. Björk, U. Lindahl, 1984, The Journal of biological chemistry.

Artificial surface-induced cytokine synthesis: effect of heparin coating and complement inhibition.

T. Mollnes, M. Fung, K. Lappegård, 2004, The Annals of thoracic surgery.

Effect of complement inhibition and heparin coating on artificial surface-induced leukocyte and platelet activation.

John D Lambris, J. Lambris, V. Videm, 2004, The Annals of thoracic surgery.

Role of granulocytes and monocytes in the polyvinyl chloride-induced synthesis of interleukin 8, monocyte chemoattractant protein 1, and leukotriene B4.

Joseph Sexton, T. Mollnes, K. Lappegård, 2005, Journal of biomedical materials research. Part A.

Differential effect of heparin coating and complement inhibition on artificial surface-induced eicosanoid production.

John D Lambris, J. Lambris, T. Mollnes, 2005, The Annals of thoracic surgery.

The artificial surface-induced whole blood inflammatory reaction revealed by increases in a series of chemokines and growth factors is largely complement dependent.

John D Lambris, J. Lambris, T. Mollnes, 2008, Journal of biomedical materials research. Part A.

The molecular size of the antithrombin‐binding sequence in heparin

U. Lindahl, L. Thunberg, G. Bäckström, 1980, FEBS letters.

Biosynthesis of heparan sulfate in rat liver. Characterization of polysaccharides obtained with intact cells and with a cell-free system.

U. Lindahl, J. Riesenfeld, M. Hözok, 1982, The Journal of biological chemistry.

Biosynthesis of heparin. Assay and properties of the microsomal N-acetyl-D-glucosaminyl N-deacetylase.

M. Höök, U. Lindahl, J. Riesenfeld, 1980, The Journal of biological chemistry.

Biosynthesis of heparin. O-sulfation of the antithrombin-binding region.

M. Petitou, J. Choay, U. Lindahl, 1988, The Journal of biological chemistry.

Biosynthesis of heparin. Concerted action of early polymer-modification reactions.

M. Höök, U. Lindahl, J. Riesenfeld, 1982, The Journal of biological chemistry.

The antithrombin-binding sequence of heparin. Location of essential N-sulfate groups.

M. Höök, U. Lindahl, L. Thunberg, 1981, The Journal of biological chemistry.

Effect of surface-immobilized heparin on the activation of adsorbed factor XII.

G. Elgue, N. Egberg, P. Olsson, 2008, Artificial organs.

Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system.

D. Feingold, U. Lindahl, K. Lidholt, 1988, The Biochemical journal.

Complement activation and bioincompatibility. The terminal complement complex for evaluation and surface modification with heparin for improvement of biomaterials.

E. Fosse, V. Videm, J. Svennevig, 2008, Clinical and experimental immunology.

Interaction of lipoprotein lipase with native and modified heparin-like polysaccharides.

T. Olivecrona, M. Höök, U. Lindahl, 1980, The Biochemical journal.

Structure and biosynthesis of heparin-like polysaccharides.

A. Malmström, D. Feingold, M. Höök, 1977, Federation proceedings.

Biosynthesis of heparin

I. Pettersson, W. Vann, U. Lindahl, 1986, Glycoconjugate Journal.

Binding of antithrombin to immobilized heparin under varying flow conditions.

G. Elgue, P. Olsson, B. Pasche, 1991, Artificial organs.

The antithrombin-binding sequence of heparin.

U. Lindahl, L. Thunberg, G. Bäckström, 1981, Biochemical Society transactions.

Inhibition of the plasma contact activation system of immobilized heparin: relation to surface density of functional antithrombin binding sites.

G. Elgue, P. Olsson, J. Riesenfeld, 1997, Journal of biomedical materials research.

Control of contact activation on end-point immobilized heparin: the role of antithrombin and the specific antithrombin-binding sequence.

G. Elgue, P. Olsson, J. Riesenfeld, 1995, Journal of biomedical materials research.

Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood.

T. Mollnes, D. Christiansen, M. Fung, 2008, Molecular Immunology.

Studies of adsorption, activation, and inhibition of factor XII on immobilized heparin.

G. Elgue, P Olsson, J Sanchez, 1998, Thrombosis research.

Surface modification with functionally active heparin.

T. Mollnes, P. Olsson, J. Riesenfeld, 1995, Medical device technology.

On the blood compatibility of end-point immobilized heparin

T. Mollnes, P. Olsson, J. Riesenfeld, 2000, Journal of biomaterials science. Polymer edition.

A new model for evaluation of biocompatibility: combined determination of neoepitopes in blood and on artificial surfaces demonstrates reduced complement activation by immobilization of heparin.

E. Fosse, O. Götze, E. Nordström, 1995, Artificial organs.

Structure of the Antithrombin III-Binding site in Heparin

A. Linker, L. Fransson, U. Lindahl, 1979, Thrombosis and Haemostasis.

Antithrombin III Binding to Surface Immobilized Heparin and Its Relation to F Xa Inhibition

O. Larm, J. Swedenborg, P. Olsson, 1987, Thrombosis and Haemostasis.

Platelet Compatibility of an Artificial Surface Modified with Functionally Active Heparin

V. Videm, T. Hovig, T. Mollnes, 1999, Thrombosis and Haemostasis.

Heparin surfaces: Impact of immobilization chemistry on hemocompatibility and protein adsorption.

Clayton J. Underwood, R. Biran, J. Andersson, 2014, Journal of biomedical materials research. Part B, Applied biomaterials.

On the Mechanism of Coagulation Inhibition on Surfaces with End Point Immobilized Heparin

G. Elgue, P. Olsson, J. Riesenfeld, 1993, Thrombosis and Haemostasis.

Biosynthesis of heparin. Effects of n-butyrate on cultured mast cells.

U. Lindahl, J. Riesenfeld, K. Jacobsson, 1985, The Journal of biological chemistry.

A nonelutable low-molecular weight heparin stent coating for improved thromboresistance.

C. Rogers, R. Falotico, Yan Cheng, 2012, Journal of biomedical materials research. Part B, Applied biomaterials.